{
    "Trade/Device Name(s)": [
        "MultiSure GK Link Blood Glucose and Ketone Monitoring System"
    ],
    "Submitter Information": "Apex Biotechnology Corp.",
    "510(k) Number": "K201880",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091547",
        "K170267",
        "K182593"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "NBW",
        "JIN"
    ],
    "Summary Letter Date": "February 9, 2021",
    "Summary Letter Received Date": "February 12, 2021",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1435"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Ketones (nonquantitative) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Glucose",
        "\u03b2-Hydroxybutyrate (Ketone)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MultiSure GK Blood Glucose and Ketone Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase enzymatic reaction",
        "\u03b2-Hydroxybutyrate dehydrogenase enzymatic reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for MultiSure GK Link Blood Glucose and Ketone Monitoring System for self-testing of blood glucose and ketone at home using electrochemical biosensor technology",
    "Indications for Use Summary": "Intended to quantitatively measure blood glucose or blood ketone in fresh capillary whole blood from fingertips for self-testing by people with diabetes mellitus at home to monitor effectiveness of diabetes control; not intended for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}